On 07 March 2020, TransMedics Group, Inc. (NASDAQ: TMDX) stock observed trading -54.98% off 52-week high price. On the other end, the stock has been noted 40.59% away from low price over the last 52-weeks. The stock disclosed a move of -18.33% away from 50 day moving average and -31.73% away from 200 day moving average. Moving closer, we can see that shares have been trading -7.80% off 20-day moving average.
TransMedics Group, Inc TMDX) recently stated financial results for the quarter and year ended December 28, 2019.
Fourth Quarter 2019 Financial Results
Net revenue for the fourth quarter of 2019 was $6.1M, a 71% increase contrast to $3.5M in the fourth quarter of 2018. The increase in revenue was driven by OCS Lung adoption and ongoing OCS Heart EXPAND CAP and DCD Heart trials.
Gross margin for the fourth quarter of 2019 was 62% as contrast to 42% in the fourth quarter of 2018. The continued improvement in gross margin was largely Because of the increasing numbers of commercial sales and a higher percentage of domestic sales.
Operating expenses for the fourth quarter of 2019 were $12.4M contrast to $7.9M in the fourth quarter of 2018. The increase in operating expenses was primarily driven by higher SG&A costs stemming from investments in our commercial team and costs associated with being a public company. In addition, costs associated with supporting clinical trials and product development drove R&D expenses as contrast to the fourth quarter of 2018.
Net loss for the fourth quarter of 2019 was $9.2M contrast to $7.6M in the fourth quarter of 2018.
Cash, cash equivalents and marketable securities were $80.7M as of December 28, 2019.
Full Year 2019 Financial Results
Net revenue for the full year 2019 was $23.6M, an 81% increase contrast to $13.0M in full year 2018.
Gross margin for the full year 2019 was 59% as contrast to 44% in full year 2018.
Operating expenses for the full year 2019 were $43.5M contrast to $26.0M in full year 2018.
Net loss for the full year 2019 was $33.5M contrast to $23.8M in full year 2018.
The USA based company TransMedics Group, Inc. moved with change of 11.99% to $14.2 with the total traded volume of 194773 shares in recent session versus to an average volume of 179.47K. The average volatility for the week and month was at 22.08% and 11.38% respectively. There are 24.14M shares outstanding and 16.18M shares are floated in market.